SHAYLA ARCENEAUX: Open Payments
NPI 1326464207 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,686 in 223 payments from 23 companies in 2025. Trend: 2023 $3,812 · 2024 $2,644 · 2025 $3,686
Food & beverage: $3,512Education: $175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $501 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 19 | $485 |
| Novartis Pharmaceuticals Corporation | 26 | $319 |
| Organon LLC | 20 | $290 |
| Incyte Corporation | 9 | $254 |
| E.R. Squibb & Sons, L.L.C. | 24 | $230 |
| Regeneron Healthcare Solutions, Inc. | 11 | $209 |
| Botanix SB Inc | 10 | $200 |
| Almirall LLC | 15 | $196 |
| Arcutis Biotherapeutics, Inc. | 14 | $183 |
Products named: DUPIXENT, OPZELURA, SKYRIZI, Sotyktu, ILUMYA, COSENTYX, SOFDRA, Seysara.
Industry payments across TX — which companies pay providers there.
